The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 Weeks
Clinical trial NCT03931239 · COMPLETED
Trial details
- NCT number
- NCT03931239
- Sponsor
- Vabiotech
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-01
- Primary completion
- 2018-06-30
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.